Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-004607
Filing Date
2012-03-08
Accepted
2012-03-08 16:10:56
Documents
1
Period of Report
2012-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3828
  Complete submission text file 0001179110-12-004607.txt   5202
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 12677419

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations